상단으로
Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Seegene names Dr. Lothar Kruska as new president of its German branch
Jan 05, 2016
?
In January this year, Seegene named Dr. Lothar Kruska as the new president of its German branch.
?
President Kruska previously worked for Limbach Group, the largest commercial lab in Germany, for 21 years. He played a significant role in introducing and successfully setting the PCR-based genetic testing and Multiplex Diagnostics systems in the lab. Having served as a leader of a team of experts within a major commercial lab, President Kruska has a high standing and is very well-known in the German medical market as an authority on PCR-based molecular diagnosis.
?
President Kruska stated, “While the German medical device market is one of the largest in Europe, it is a bit slow in accepting changes. Nevertheless, the molecular diagnosis sector is currently expanding rapidly.” He explained, “As a consumer who has used Seegene’s molecular diagnosis products before, I am well aware that Seegene’s powerful and accurate multiplex technology not only saves test time and costs, but also provides a much broader range of information on pathogens per test. I am certain that demand for Seegene products will continue to grow.
?
Thus far, Seegene has gained CE-IVD certification for over 40 products, including its multiplex detection products for respiratory infections, STIs, HPVs, TB and the drug resistance detection and more.
The appointment of President Kruska is expected to allow Seegene to embark on an aggressive localization marketing strategy, based on his extensive experience with large commercial labs and profound understanding of the medical device market in Germany and other European countries.